These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6335134)
41. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms. Sakamoto M; Ishikura T; Fukagawa Y J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679 [TBL] [Abstract][Full Text] [Related]
42. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. Tzouvelekis LS; Tzelepi E; Kaufmann ME; Mentis AF J Med Microbiol; 1994 Jun; 40(6):403-7. PubMed ID: 8006932 [TBL] [Abstract][Full Text] [Related]
43. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity. Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360 [TBL] [Abstract][Full Text] [Related]
44. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37. Ahmed AM; Shimamoto T Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820 [TBL] [Abstract][Full Text] [Related]
45. Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains. Ahmed A; Hafiz S; Ahmed QT; Majeed H; Syed S J Pak Med Assoc; 1998 Jun; 48(6):158-61. PubMed ID: 9813984 [TBL] [Abstract][Full Text] [Related]
46. In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland. Liassine N; Bille J; Breer C; Frei R; Wüst J; Auckenthaler R Scand J Infect Dis; 1997; 29(6):615-21. PubMed ID: 9571744 [TBL] [Abstract][Full Text] [Related]
47. Regulatory components in Citrobacter freundii ampC beta-lactamase induction. Lindberg F; Westman L; Normark S Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4620-4. PubMed ID: 2991883 [TBL] [Abstract][Full Text] [Related]
48. Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins. Labia R; Morand A; Tiwari K; Sirot D; Chanal C J Antimicrob Chemother; 1989 Sep; 24 Suppl A():219-23. PubMed ID: 2808209 [TBL] [Abstract][Full Text] [Related]
49. Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase. Lindberg F; Lindquist S; Normark S J Bacteriol; 1987 May; 169(5):1923-8. PubMed ID: 3032901 [TBL] [Abstract][Full Text] [Related]
50. The threat of resistance to the new oral cephalosporins. Cullmann W Chemotherapy; 1992; 38 Suppl 2():10-7. PubMed ID: 1516458 [TBL] [Abstract][Full Text] [Related]
51. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals]. Babálová M; Krălíková K; Krcméry V; Kubonová K Cas Lek Cesk; 1996 Mar; 135(6):181-4. PubMed ID: 8681362 [TBL] [Abstract][Full Text] [Related]
52. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli. Bujdáková H; Kallová J; Lausová A; Kettner M Microbios; 1995; 84(339):87-90. PubMed ID: 8628124 [TBL] [Abstract][Full Text] [Related]
53. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics. Jan IS; Hsueh PR; Teng LJ; Ho SW; Luh KT J Formos Med Assoc; 1998 Oct; 97(10):661-6. PubMed ID: 9830274 [TBL] [Abstract][Full Text] [Related]
54. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime. Bauernfeind A J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170 [TBL] [Abstract][Full Text] [Related]
55. Antibiotic sensitivity pattern of Citrobacter isolated from various clinical specimens in a tertiary care hospital. Shetty J; Kotigadde S Indian J Pathol Microbiol; 2007 Jul; 50(3):666-8. PubMed ID: 17883179 [TBL] [Abstract][Full Text] [Related]
56. Interactions of meropenem with class I chromosomal beta-lactamases. Yang YJ; Livermore DM J Antimicrob Chemother; 1989 Sep; 24 Suppl A():207-17. PubMed ID: 2808208 [TBL] [Abstract][Full Text] [Related]
57. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Chen HY; Livermore DM J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068 [TBL] [Abstract][Full Text] [Related]
58. Cefclidin (E1040), a novel cephalosporin: lack of selection of beta-lactamase overproducing mutants in an in vitro pharmacokinetic model system. Watanabe NA; Katsu K J Antibiot (Tokyo); 1992 Aug; 45(8):1335-45. PubMed ID: 1399855 [TBL] [Abstract][Full Text] [Related]
59. Whole-genome sequencing enabling the detection of a colistin-resistant hypermutating Citrobacter werkmanii strain harbouring a novel metallo-β-lactamase VIM-48. Peter S; Bezdan D; Oberhettinger P; Vogel W; Dörfel D; Dick J; Marschal M; Liese J; Weidenmaier C; Autenrieth I; Ossowski S; Willmann M Int J Antimicrob Agents; 2018 Jun; 51(6):867-874. PubMed ID: 29412174 [TBL] [Abstract][Full Text] [Related]
60. High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2. Kanamori H; Yano H; Hirakata Y; Endo S; Arai K; Ogawa M; Shimojima M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Kitagawa M; Kunishima H; Kaku M J Antimicrob Chemother; 2011 Oct; 66(10):2255-62. PubMed ID: 21733965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]